Cargando…
Anti‐PCSK9 antibodies for hypercholesterolaemia: Overview of clinical data and implications for primary care
OBJECTIVES: To put data from our recent systematic review of phase 3 studies of anti‐proprotein convertase subtilisin/kexin type 9 (PCSK9) antibodies into the context of clinical practice. METHODS: Data from studies previously identified by a systematic review of phase 3 studies of alirocumab and ev...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601297/ https://www.ncbi.nlm.nih.gov/pubmed/28750477 http://dx.doi.org/10.1111/ijcp.12979 |